Description
CHEMISTRY&IMMUNOASSAY CPRR - VISN 21
First action · last action
2017-03-28 · 2023-10-06
Transactions
11
First transaction's obligation
$303,788
Base + all options value (sum of deltas)
$2,264,707
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
4
SDVOSB flag on record
No
Parent IDV
V797P7090A
NAICS
334516 · ANALYTICAL LABORATORY INSTRUMENT MANUFACTURING
Modification chain · 11 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2017-03-28+$303,788= $303,788
- Mod P000012017-10-05+$607,575= $911,363
- Mod P000022019-09-02+$607,575= $1,518,938
- Mod P000042019-10-01+$607,575= $2,126,513
- Mod P000062020-03-26+$0= $2,126,513
- Mod P000072020-10-01+$607,576= $2,734,088
- Mod P000082021-02-25-$593,357= $2,140,732
- Mod P000092021-10-01+$303,788= $2,444,519
- Mod P000102022-03-25+$303,788= $2,748,307
- Mod P000112022-12-21-$221,838= $2,526,469
- Mod P000122023-10-06-$261,762= $2,264,707
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2017-03-28 | +$303,788 | $303,788 | CHEMISTRY&IMMUNOASSAY CPRR - VISN 21 |
| Mod P00001· EXERCISE AN OPTION | 2017-10-05 | +$607,575 | $911,363 | CHEMISTRY&IMMUNOASSAY CPRR - VISN 21 |
| Mod P00002· OTHER ADMINISTRATIVE ACTION | 2019-09-02 | +$607,575 | $1,518,938 | CHEMISTRY&IMMUNOASSAY CPRR - VISN 21 |
| Mod P00004· EXERCISE AN OPTION | 2019-10-01 | +$607,575 | $2,126,513 | CHEMISTRY&IMMUNOASSAY CPRR - VISN 21 |
| Mod P00006· OTHER ADMINISTRATIVE ACTION | 2020-03-26 | +$0 | $2,126,513 | CHEMISTRY&IMMUNOASSAY CPRR - VISN 21 |
| Mod P00007· EXERCISE AN OPTION | 2020-10-01 | +$607,576 | $2,734,088 | CHEMISTRY&IMMUNOASSAY CPRR - VISN 21 |
| Mod P00008· FUNDING ONLY ACTION | 2021-02-25 | −$593,357 | $2,140,732 | CHEMISTRY&IMMUNOASSAY CPRR - VISN 21 |
| Mod P00009· EXERCISE AN OPTION | 2021-10-01 | +$303,788 | $2,444,519 | CHEMISTRY&IMMUNOASSAY CPRR - VISN 21 |
| Mod P00010· EXERCISE AN OPTION | 2022-03-25 | +$303,788 | $2,748,307 | CHEMISTRY&IMMUNOASSAY CPRR - VISN 21 |
| Mod P00011· FUNDING ONLY ACTION | 2022-12-21 | −$221,838 | $2,526,469 | CHEMISTRY&IMMUNOASSAY CPRR - VISN 21 |
| Mod P00012· FUNDING ONLY ACTION | 2023-10-06 | −$261,762 | $2,264,707 | CHEMISTRY&IMMUNOASSAY CPRR - VISN 21 |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI PU6HHX2R11C7)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C26226N0869 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $111,853 | FY2026 |
| 36C25726N0476 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $1,450,556 | FY2026 |
| 36C25926N0424 | NETWORK CONTRACT OFFICE 19 (36C259) · 6630 · CHEMICAL ANALYSIS INSTRUMENTS | $2,989,154 | FY2026 |
| 36C25726N0456 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $365,580 | FY2026 |
| 36C24426N0923 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · Q301 · REFERENCE LABORATORY TESTING | $84,816 | FY2026 |
| 36C24426N0922 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · Q301 · REFERENCE LABORATORY TESTING | $46,600 | FY2026 |
Other recipients under 6630 from 261-NETWORK CONTRACT OFFICE 21 (36C261) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C26126F0309 | BIOMERIEUX INC | 261-NETWORK CONTRACT OFFICE 21 (36C261) | $360,089 | FY2026 |
| 36C26126N0375 | BIOMERIEUX INC | 261-NETWORK CONTRACT OFFICE 21 (36C261) | $136,706 | FY2026 |
| 36C26126N0135 | POLYMEDCO CANCER DIAGNOSTIC PRODUCTS LLC | 261-NETWORK CONTRACT OFFICE 21 (36C261) | $37,831 | FY2026 |
| 36C26126F0020 | BIOMERIEUX INC | 261-NETWORK CONTRACT OFFICE 21 (36C261) | $278,149 | FY2026 |
| 36C26126N0078 | ORTHO-CLINICAL DIAGNOSTICS, INC | 261-NETWORK CONTRACT OFFICE 21 (36C261) | $154,375 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA26117F1601_3600_V797P7090A_3600 · retrieved 2026-09-26.